
ken drazan
@kdrazan
Leading ArsenalBio, Dad, Husband, Double dog owner, stay fit.
ID: 1184808914753220608
17-10-2019 12:30:47
511 Tweet
347 Followers
252 Following





Proud and impressed by the ArsenalBio team once again. Another step towards our goal.



Thank you Endpoints News for honoring ArsenalBio




Today: FDA announced it is investigating the risk of T-cell malignancy following BMCA & CD19 autologous CAR-T. Last week: BiotechTV discussed this issue with one cell therapy company (ArsenalBio) and heard how their thesis from the beginning has been to try to avoid it.




Our CEO, ken drazan, MD, will present at the J.P. Morgan Healthcare Conference on Monday, Jan. 13 at 4pm PT. He'll discuss our progress in developing cell therapies for solid tumors and the strides we’re making toward defeating cancer. #JPM2025 bit.ly/4gZhWFV


Join us in welcoming Karen Knudsen, MBA PhD as PICI's Chief Executive Officer! A visionary in oncology, healthcare delivery & nonprofit strategy, Dr. Knudsen embodies the values that define PICI: scientific rigor, bold thinking & a commitment to transformative patient impact. (1/3)

ArsenalBio CSO Nick Haining recently spoke with Drug Discovery News about our multi-pronged approach of equipping T cells to defeat solid tumors. Check out the article, "Armoring up CAR T cells to fight solid tumors" at bit.ly/4i0LRO5 #CancerResearch #CellTherapy


